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Introduction
SP-C (surfactant protein C) is a transmembrane protein that is 
synthesized as a 191– or 197–amino acid proprotein by type II 
epithelial cells of the lung. Processing of the proprotein in the 
distal secretory pathway liberates a 35–amino acid peptide that is 
secreted into the airspaces as a component of pulmonary surfac-
tant. Mutations in the gene encoding SP-C (SFTPC) have been 
associated with the development of sporadic and familial inter-
stitial lung disease (ILD). In all cases to date, the mutation was 
present on only one allele consistent with a dominant-negative 
effect. The index mutation, a heterozygous base substitution 
of A for G at the fi  rst base of intron 4 (c.460 + 1 G→A), led to 
the internal deletion of 37 amino acids from the ER luminal 
domain, generating a truncated proprotein (SP-C
∆exon4; Nogee 
et al., 2001). Two separate SFTPC mutations associated with 
ILD, SP-C
L188Q and SP-C
I73T, were detected in three kindreds 
(Thomas et al., 2002a; Chibbar et al., 2004; Cameron et al., 
2005). The age of onset and penetrance of ILD varied markedly 
in all three kindreds.
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Studies in transiently transfected cells suggested that 
the c.460 + 1 G→A mutation led to misfolding of the mutant 
proprotein, retention of SP-C
wt in the ER, activation of the 
unfolded protein response (UPR), and apoptosis (Bridges 
et al., 2003; Wang et al., 2003; Mulugeta et al., 2005). SP-C
∆exon4 
was also associated with cytotoxicity and lung dysmorpho-
genesis when expressed in type II cells of transgenic mice 
(Bridges et al., 2003). The UPR is activated by conditions that 
perturb ER homeostasis, including the accumulation of mis-
folded proteins (Schroder and Kaufman, 2005). This response 
encompasses translational and transcriptional changes within 
the cell to alleviate the stress and to promote restoration of 
ER homeostasis. A model for the time-dependent induction of 
the UPR has been proposed, suggesting that translational 
  repression via PERK activation/eIF2α phosphorylation oc-
curs fi  rst followed by the cleavage of ATF6, activation of 
IRE1/XBP-1, and expression of ATF6 and XBP-1 target genes 
(Yoshida et al., 2003). If ER homeostasis cannot be restored 
by these pathways or by the induction of adaptive responses, 
apoptosis may occur as a means of avoiding the untoward 
  effects of cell necrosis. ER stress–induced apoptosis has been 
associated with induction of the transcription factor C/EBP 
homologous protein, activation of c-Jun amino-terminal 
  kinase via IRE1, and activation of the ER stress–specifi  c 
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M
utations in the gene encoding SP-C (surfactant 
protein C; SFTPC) have been linked to interstitial 
lung disease (ILD) in children and adults. Ex-
pression of the index mutation, SP-C
∆exon4, in transiently 
transfected cells and type II cells of transgenic mice re-
sulted in misfolding of the proprotein, activation of endo-
plasmic reticulum (ER) stress pathways, and cytotoxicity. In 
this study, we show that stably transfected cells adapted to 
chronic ER stress imposed by the constitutive expression of 
SP-C
∆exon4 via an NF-κB–dependent pathway. However, 
the infection of cells expressing SP-C
∆exon4 with respiratory 
syncytial virus resulted in signiﬁ  cantly enhanced cytotoxic-
ity associated with accumulation of the mutant proprotein, 
pronounced activation of the unfolded protein response, 
and cell death. Adaptation to chronic ER stress imposed by 
misfolded SP-C was associated with increased susceptibil-
ity to viral-induced cell death. The wide variability in the 
age of onset of ILD in patients with SFTPC mutations may 
be related to environmental insults that ultimately over-
whelm the homeostatic cytoprotective response.T
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 caspases 4 (human; Hitomi et al., 2004) and 12 (mouse; Nakagawa 
et al., 2000; Urano et al., 2000; Hetz et al., 2003; for review 
see Oyadomari and Mori, 2004). Although the effects of acute 
ER stress, which is imposed by xenotoxic agents such as 
thapsigargin and tunicamycin, are well established, little is 
known about the molecular pathways involved in adaptation 
to chronic ER stress imposed by a misfolded protein.
The variability in the age of onset and penetrance of dis-
ease in the SP-C
L188Q and SP-C
I73T pedigrees suggests that both 
genetic and environmental factors may infl  uence the manifesta-
tion of lung disease. Based on the results of the aforementioned 
studies in human patients and transiently transfected cells, ex-
periments were designed to test the hypotheses that (1) chronic 
ER stress imposed by misfolded SP-C promotes adaptation and 
cell survival and (2) adaptation increases susceptibility to envi-
ronmental stress. Clonal cell lines stably expressing SP-C
∆exon4 
or SP-C
wt were generated to identify cytoprotective pathways 
that are associated with adaptation to the constitutive expres-
sion of misfolded SP-C and to assess the cytotoxic effects of 
  environmental stress on adapted cells.
Results
Generation and characterization of stably 
transfected cell lines
To determine the molecular mechanisms underlying   SP-C
∆exon4-
induced cytotoxicity, HEK293 cell lines stably expressing 
SP-C
wt or SP-C
∆exon4 were generated. Multiple clonal lines were 
obtained for each construct, and two lines were chosen for 
subsequent experimentation based on equivalent expression of 
SP-C mRNA, which was initially assessed by RT-PCR (Table I) 
and subsequently confi  rmed by microarray analysis (Fig. 1 b). 
These cell lines were morphologically indistinguishable by 
light microscopy (Fig. 1 a) or electron microscopy   (not de-
picted) and exhibited similar doubling rates (not depicted). 
Basal SP-C protein levels were assessed by Western blot 
  analysis of cell lysates with an antibody directed against the 
NH2-terminal peptide of the proprotein (proSP-C), a region 
which is unaffected by the ∆exon4 mutation. Despite equiva-
lent mRNA levels, expression of the SP-C
∆exon4 protein was 
barely detectable compared with SP-C
wt, which is consistent 
Figure 1.  Generation of clonal stably transfected cell lines. (a) Phase light micrographs of stably transfected HEK293 cell lines expressing SP-C
wt or 
SP-C
∆exon4. (b) Expression of SP-C mRNA in the two cell lines. Error bars represent SD. (c) 30 μg of cell lysates were subjected to immunoblot analysis using 
antibody directed against the NH2 terminus of proSP-C to detect SP-C
wt (Mr = 21 k) and SP-C
∆exon4 (Mr = 17 k). (d and e) Subcellular localization of 
SP-C
wt to lysosomes (d) and SP-C
∆exon4 to ER (e) in clonal cell lines by confocal microscopy. Bars (a and d), 20 μm; (e) 10 μm.T
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Table I. Transcriptional proﬁ  ling reveals differential expression of genes associated with apoptosis in SP-C
𝖫exon4 cells
Fold change
(microarray)
Fold change
(real-time PCR) Gene Description Function
a NF-𝗋B–binding sites
+4.8 +4.2    MYC V-myc myelocytomatosis viral
  oncogene homologue (avian)
Regulation of apoptosis 1
+2.3 ND SNCA Synuclein, α Anti 1
+2.1 ND PROK2 Prokineticin 2 Anti 1
+1.7 +2.9   IKBKG Inhibitor of κ-light polypeptide 
  gene enhancer in B cells,
 kinase  γ
Pro 1
+1.6 ND PBEF Pre–B cell colony–enhancing
 factor  1
Anti 1
+1.6 ND BNIP1 Bcl2/adenovirus E1B 19-kD
  interacting protein 1
Anti and pro 2
+1.5 ND MAPK14 Mitogen-activated protein
 kinase  14
Anti 2
+1.5 ND MYB V-myb myeloblastosis viral
  oncogene homologue (avian)
Regulation of apoptosis 1
+2.1 ND PDCD8 Programmed cell death 8 Pro 0
+2.0 ND HRK Harakiri, Bcl2-interacting
 protein
Pro 0
+1.8 ND HTATIP2 HIV-1 Tat interactive protein 2 Anti 0
+1.7 ND BCAP31 B cell receptor–associated
 protein  31
Apoptosis 0
+1.6 ND PLAGL1 Pleiomorphic adenoma 
 genelike  1
Pro 0
+1.6 ND BAX Bcl2-associated X protein Pro 0
+1.6 ND P8 P8 protein Pro 0
+1.6 ND BAG2 Bcl2-associated athanogene 2 Apoptosis 0
+1.6 ND MRPS30 Mitochondria ribosomal 
 protein  S30
Apoptosis 0
+1.5 ND TNFRSF6 TNF receptor superfamily,
 member  6
Anti 0
−3.0 ND SFRP1 Secreted frizzled rp1 Anti 2
−3.0 ND CD24 CD24 antigen Pro 1
−2.1 ND FLI1 Friend leukemia virus
 integration  1
Cell death 1
−2.0 ND RUNX3 Runt-related transcription
 factor  3
Apoptosis 2
−1.6 ND PSEN1 Presenilin 1 Anti 1
−1.6 ND CDC2L2 Cell division cycle 2–like 2 Apoptosis 1
−1.6 −3.6    DUSP6 Dual speciﬁ  city phosphatase 6 Apoptosis 1
−3.0 ND TGF-β1 Transforming growth factor β1 Anti 0
−2.1 ND Bcl2 B cell CLL/lymphoma 2 Anti 0
−1.9 ND PHLDA2 Pleckstrin homology-like DA2 Apoptosis 0
−1.9 ND AKT1 V-akt murine thymoma viral 
 oncogene
Anti 0
−1.7 ND TIA1 RNA-binding protein Apoptosis 0
−1.8 ND PTPN6 Protein tyrosine phosphatase N6 Apoptosis 0
−1.7 ND PRKCZ Protein kinase C, ζ Anti 0
−1.7 ND MCL1 Bcl-2 related protein Anti and pro 0
+1.7 +2.3    IRAK1 IL-1 receptor-associated kinase 1 NF-κB pathway 0
The clonal cell lines expressing SP-C
wt, SP-C
∆exon4, or empty vector were subjected to transcriptional proﬁ  ling using the human U133 gene chip set from Affymetrix. 
Genes that were speciﬁ  cally increased or decreased in SP-C
∆exon4 over both SP-C
wt and an empty vector control (i.e., mutant-speciﬁ  c changes) are reported as 
fold changes from microarray analysis (ﬁ  rst column). Select targets were validated by real-time PCR (second column). The last column lists the number of putative 
NF-κB–binding sites located in the 5′ ﬂ  anking sequence (1 kb) of the gene on the left. Data represent the mean of three analyses for each genotype.
aAnti and pro designations signify anti- and pro-apoptosis; evidence of apoptosis is from the Gene Ontology database.
with rapid proteasome-dependent turnover of the mutant pro-
protein (Fig. 1 c).
SP-C
∆exon4 protein was previously shown to be rapidly de-
graded in a proteasome-dependent manner and failed to be ex-
ported from the ER when transiently expressed in HEK293 cells 
(Bridges et al., 2003). To determine the subcellular localization 
of the SP-C variants in stably transfected cell lines, cells were 
stained with antibodies directed against proSP-C and LAMP-1 
and analyzed by confocal microscopy. A bright, punctuate stain-
ing pattern was observed for proSP-C in SP-C
wt cells, whereas 
cells expressing SP-C
∆exon4 showed faint, diffuse staining that 
was detected only in the presence of   proteasome inhibitor JCB • VOLUME 172 • NUMBER 3 • 2006  398
(Fig. 1 d). SP-C
wt traffi  cs to the lamellar body in type II cells but 
is redirected to the lysosome in cells that lack lamellar bodies 
(for reviews see Dell’Angelica et al., 2000; Weaver et al., 2002). 
Colocalization of SP-C
wt with the lysosomal marker LAMP-1 
demonstrated effi  cient export of wild-type protein from the ER 
(Fig. 1 d). In contrast, SP-C
∆exon4 exhibited a faint and diffuse 
staining pattern that colocalized with an anti-KDEL antibody, 
an ER marker (Fig. 1 e). These data in clonal cell lines, coupled 
with previous results in transiently transfected cells (Bridges 
et al., 2003), suggest that SP-C
wt is correctly folded and ex-
ported from the ER, whereas SP-C
∆exon4 fails quality control and 
is rapidly   degraded by the proteasome.
Transcriptional proﬁ  ling reveals differential 
expression of genes associated 
with apoptosis in SP-C
𝖫exon4 cells
Molecular pathways induced by the chronic expression of 
SP-C
∆exon4 were identifi  ed by transcriptional profi  ling of SP-C
wt 
and SP-C
∆exon4 clonal cell lines (the complete dataset can be 
found at http://www.ncbi.nlm.nih.gov/geo/; GenBank/EMBL/
DDBJ accession no. GSE2980). Unexpectedly, known com-
ponents of the UPR/ER-associated degradation (ERAD) path-
ways were not increased in cells that constitutively expressed 
SP-C
∆exon4, which is in contrast to results in transiently trans-
fected cells (Bridges et al., 2003). However, several genes asso-
ciated with anti- and pro-apoptosis pathways were differentially 
expressed in the SP-C
∆exon4 clonal cell line, including BAX and 
Bcl-2 (Table I, Fig. S1, and Table S1; available at http://www.
jcb.org/cgi/content/full/jcb.200508016/DC1). Interestingly, two 
transcripts linked to the NF-κB pathway, interleukin-1 receptor-
associated 1 (IRAK1) and the γ subunit of the Iκ-B kinase com-
plex (IKBKG), were increased in the SP-C
∆exon4 cells, which is 
consistent with alterations in the NF-κB signaling pathway. 
  Analyses of the 5′ fl  anking sequences of apoptosis-associated 
genes revealed that  44% (15/34) contained putative NF-κB bind-
ing sites, suggesting that they may be direct targets of NF-κB.
To determine whether NF-κB activity was increased in 
SP-C
∆exon4 cells, an NF-κB luciferase reporter construct was 
transiently transfected into the clonal cell lines. SP-C
∆exon4 cells 
exhibited an 8.6-fold increase in basal NF-κB activity com-
pared with cells stably transfected with empty vector or SP-C
wt 
(Fig. 2 a).  Cotransfection of a stabilized, nonphosphorylatable 
form of I-κBα (super repressor [SR]) with the NF-κB reporter 
resulted in a dose-dependent decrease in luciferase activity 
in SP-C
∆exon4 cells that was completely suppressed to levels 
detected in untreated SP-C
wt cells (Fig. 2 b). IκBα protein in 
SP-C
∆exon4 cells was decreased compared with SP-C
wt cells, 
which is consistent with increased NF-κB activity (Fig. 2 c). 
Treatment of SP-C
∆exon4 cells with SN50 peptide to inhibit the 
nuclear translocation of NF-κB resulted in cellular retraction 
and a signifi  cant increase in cell death, as indicated by prop-
idium iodide (PI) staining (Fig. 3 a) and MTS reduction assay (Fig. 3 c).  
Treatment of SP-C
∆exon4 cells with a control peptide, SN50mut, at 
equivalent doses and duration had no effect (Fig. 3 b). Cells ex-
pressing SP-C
wt were unaffected by SN50 or SN50
mut treatment 
(not depicted). Treatment of SP-C
∆exon4 cells with SN50 decreased 
basal NF-κB activity as measured by a NF-κB reporter (Fig. 3 d) 
and inhibited nuclear translocation of the p65 subunit of NF-κB 
(Fig. 3 e). Altogether, these results suggest that NF-κB, mediated 
in part by the p65 subunit, plays an important cytoprotective role 
in adaptation to the constitutive expression of SP-C
∆exon4.
SP-C
𝖫exon4 expression increases 
susceptibility to viral-induced death
The increased expression of pro-apoptotic transcripts in 
SP-C
∆exon4 cells (Table I) suggested that adapted cells may 
Figure 2. Basal  NF-𝗋B activity is increased in cells expressing SP-C
𝖫exon4. 
(a) The clonal cell lines expressing empty vector (EV), SP-C
wt, or SP-C
∆exon4 were 
transiently cotransfected with an NF-κB reporter construct (pELAM-Luc) and a 
plasmid encoding renilla luciferase (pRL-TK). Luciferase activity was read 48 h 
after transfection. Similar results were obtained with two additional NF-κB lu-
ciferase reporter constructs, including a minimal IL-8 promoter and a synthetic 
NF-κB promoter (not depicted). *, P < 0.05 compared with SP-C
wt. (b) SP-C
wt 
(open bars) or SP-C
∆exon4 (closed bars) clonal cell lines were transiently trans-
fected with pELAM-Luc, pRL-TK, and increasing amounts (10 pg–1 ng) of a 
plasmid encoding a super repressor of NF-κB activity (SR). EV indicates 10 ng 
of empty vector control. Groups with 10 ng/ml TNFα were treated for 12 h. 
Luciferase activity was assessed 36 h after transfection. Results are presented 
as means ± SD (error bars) of the ratio of ﬁ  reﬂ  y/renilla, expressed as relative 
luciferase units; each determination was performed in triplicate, and the ex-
periment was repeated four times. *, P < 0.05 compared with SP-C
∆exon4 un-
treated; #, P < 0 .05 compared with SP-C
wt unRx. (c) Immunoblot analysis of 
whole cell lysates using antibody directed against IκBα (top) or actin (bottom). 
Cells were treated with 5 μm MG-132 for 4 h before harvest.ADAPTATION TO MISFOLDED SP-C • BRIDGES ET AL.    399
be more susceptible to secondary stress. Infection with re-
spiratory syncytial virus (RSV) preceded the onset of ILD 
in several patients carrying the SP-C
L188Q mutation. To de-
termine whether the expression of SP-C
∆exon4 increased sus-
ceptibility to RSV, the clonal cells lines were infected at 
a multiplicity of infection (MOI) of 10 pfu/cell, and cell 
  viability was assessed 24 h after infection. Although cell vi-
ability was minimally affected in SP-C
wt cells, as indicated 
by the low level of PI staining (Fig. 4 a [b and f]), the infec-
tion of cells expressing SP-C
∆exon4 resulted in signifi  cant cell 
death (Fig. 4 a [d and h]).  Western blot analysis demon-
strated that SP-C
∆exon4 protein accumulated in a manner di-
rectly correlated with the viral titer, whereas SP-C
wt protein 
levels were unaffected (Fig. 4 b). Several viruses, including 
adenovirus, infl  uenza, and hepatitis B and C viruses, have 
been reported to induce ER stress/UPR pathways (Meyer 
et al., 1992; Pahl and Baeuerle, 1995; Pahl et al., 1996;   Tardif 
et al., 2004). To determine whether RSV activated the UPR 
in cells stably expressing SP-C, an UPR element lucifer-
ase reporter construct was transiently transfected into cells 
Figure 3.  Inhibition of NF-𝗋B nuclear translocation induces death of SP-C
𝖫exon4 cells. (a and b) The clonal cell line expressing SP-C
∆exon4 was treated with 
SN50, a cell-permeable peptide that inhibits the nuclear translocation of NF-κB (a), or a mutant SN50 peptide (SN50mut; b) at the indicated doses. Cells 
were stained with PI 24 h after the addition of peptide and phase (top), and ﬂ  uorescent (bottom) images were captured directly from the culture plate. Bars, 
50 μm. (c) Clonal cell lines expressing SP-C
wt or SP-C
∆exon4 were treated with the SN50 peptide at indicated doses for 24 h, and cell death was quantitated 
by MTS assay. (d) The clonal cell line expressing SP-C
∆exon4 was transiently cotransfected with the pELAM-Luc and pRL-TK vectors. Cells were treated with 
SN50 or SN50mut peptide 24 h after transfection at indicated doses. SR was cotransfected with pELAM-Luc and pRL-TK as positive controls. Luciferase activ-
ity was assessed 48 h after transfection. Results in c and d are presented as means ± SD (error bars); each determination was performed in triplicate, and 
the experiment was repeated three times. *, P < 0.05 compared with SP-C
∆exon4 unRx; #, P < 0.05 compared with SP-C
wt unRx. (e) Immunoblot analysis 
of nuclear extracts with an anti-p65 antibody (top) or histone H2B (bottom). SP-C
∆exon4 cells were treated with 50 μg/ml SN50 or SN50mut for 24 h before 
harvest. SP-C
wt cells were treated with 10 ng/ml TNFα for 6 h for positive control.JCB • VOLUME 172 • NUMBER 3 • 2006  400
Figure 4. SP-C
∆exon4 increases susceptibility to RSV-induced cell death. (a) Cells expressing SP-C
wt (panels a, b, e, and f) or SP-C
∆exon4 (panels c, d, g, and h) 
were infected with RSV at 10 MOI (panels b, f, d, and h). Cells were stained with propidium iodide (PI) 24 hr after infection, and phase (panels a–d) or 
  ﬂ  uorescent (panels e–h) images were captured directly from the culture plate. Bars, 50 μm. (b) Immunoblot analysis of cells expressing SP-C
wt or SP-C
∆exon4 
after infection with 0.1, 1, or 10 MOI RSV for 24 h. Immunoblots were probed with an anti–proSP-C antibody or an anti-actin antibody (load-ing control). 
(c) Clonal cell lines expressing SP-C
wt or SP-C
∆exon4 were transiently transfected with a reporter construct consisting of ﬁ  ve UPR elements driv-ing luciferase 
(UPRE-Luc) and pRL-TK. Cells were infected with 5 MOI RSV 24 h after transfection, and luciferase activity was assessed 24 h after infection. Results are pre-
sented as means ± SD (error bars) of the ratio of ﬁ  reﬂ  y/renilla, expressed as relative luciferase units; each determination was performed in triplicate, and 
the experiment was repeated four times. (d) Cell lines were transiently transfected with pELAM-Luc and pRL-TK vectors and infected with RSV at indicated 
doses 24 h after transfection. (e) SP-C
∆exon4 cells were transiently transfected with the UPRE-Luc and pRL-TK vectors. Cells were treated with SN50 or SN50mut 
peptide 24 h after transfection at indicated doses. Cells were treated with 10 μg/ml tunicamycin for 12 h for posi-tive control. (d and e) Luciferase activity 
was assessed 48 h after transfection and normalized to renilla luciferase activity. Results are presented as means ± SD; each determination was performed 
in triplicate, and the experiment was repeated three times. Data indicate fold change relative to untreated control for each genotype. (c–e) #, P < 0.05 
compared with SP-C
wt unRx; *, P < 0.05 compared with SP-C
∆exon4 unRx; ◆, P < 0.05 compared with RSV-infected SP-C
wt.
expressing SP-C
∆exon4 or SP-C
wt before infection with RSV 
(Fig. 4 c). Baseline levels of luciferase activity were simi-
lar between the cell lines, which is consistent with the mi-
croarray data, indicating that the UPR was not activated in 
cells stably expressing SP-C
∆exon4. However, luciferase activ-
ity was increased in both cell lines after RSV infection, and 
the effect was exacerbated in SP-C
∆exon4 cells (2.5-fold in-
crease in SP-C
wt vs. 4.4-fold increase in SP-C
∆exon4; Fig. 4 c). ADAPTATION TO MISFOLDED SP-C • BRIDGES ET AL.    401
Figure 5.  Proteasome function is decreased 
in RSV-infected SP-C
∆exon4 cells. (a and b) The 
clonal cell lines expressing SP-C
∆exon4 (a) or 
SP-C
wt (b) were transiently transfected with the 
proteasome sensor pZsProSensor-1 construct 
and infected with RSV at the indicated titers 
24 h after transfection. Phase (top) and ﬂ  uores-
cent (bottom) images were captured directly 
from the culture plate 24 h after infection. After 
image capture, cells were harvested and sub-
jected to FACS analysis to determine MFI 
  (reported in the top right corner of the bottom 
panels). (c) Clonal cells expressing SP-C
wt 
(panels a and c) or SP-C
∆exon4 (panels b and d) 
were transfected with a plasmid encoding 
EGFP as a control for transfection efﬁ  ciency 
(panels a and b) or with the pZsProSensor-1 
vector in the presence of MG-132 (panels 
c and d) as a positive control. Cells were har-
vested and subjected to FACS analysis 24 h 
after transfection. Values for GFP+ cells and 
mean ﬂ  uorescence intensity (MFI) are shown in 
the top right corner of each panel. Data is rep-
resentative of three independent experiments. 
Bars, 50 μm.
Furthermore, RSV-induced cell death appeared to be inde-
pendent of NF-κB, as NF-κB activity was sustained in both 
RSV-infected SP-C
∆exon4 and SP-C
wt cells (Fig. 4 d). Con-
sistent with this fi  nding, UPR activity was not induced in 
SP-C
∆exon4 cells when NF-κB activity was inhibited with 
SN50 (Fig. 4 e). Collectively, these data indicate that RSV 
infection was associated with accumulation of the mutant 
proprotein, pronounced activation of the UPR, and increased 
cell death independent of NF-κB activity.
Proteasome function is decreased 
in RSV-infected SP-C
∆exon4 cells
Accumulation of mutant SP-C proprotein in RSV-infected 
SP-C
∆exon4 cells suggested that proteasome function was JCB • VOLUME 172 • NUMBER 3 • 2006  402
  inhibited. To assess the impact of RSV infection on protea-
some activity, a proteasome reporter construct,   pZsProSensor-1, 
was transiently transfected into the clonal cell lines. Cells were 
infected with 1–10 MOI of RSV and analyzed 24 h later by 
fl   uorescence microscopy and FACS analysis. Fluorescence 
in untreated SP-C
∆exon4 cells (mean fl  uorescence  intensity 
[MFI]  = 305) was higher than that observed in untreated 
SP-C
wt cells (MFI = 156), indicating a modest inhibition of basal 
proteasome activity in the presence of the mutant proprotein 
(Fig. 5, a [e] vs. b [e]).  Infection of SP-C
∆exon4 cells with RSV 
resulted in a dose-dependent increase in fl  uorescence detected 
by microscopy and FACS (Fig. 5 a [e–h]). In contrast, fl  uores-
cence was not altered in SP-C
wt cells infected with RSV (Fig. 
5 b [e–h]). Transfection effi  ciency was similar between the two 
cell lines, and the proteasome reporter was activated in SP-C
wt 
cells treated with MG-132 (Fig. 5 c). These results demonstrate 
that basal proteasome function is decreased in   SP-C
∆exon4 cells 
and that this perturbation is exacerbated during RSV infection.
SP-C
𝖫exon4 sensitizes cells to proteasome 
inhibition and is associated with 
accumulation of mutant proprotein 
and activation of XBP-1
To determine whether decreased proteasome function induced 
ER stress and activation of apoptosis independently of RSV in-
fection, the clonal cell lines were treated with the proteasome 
inhibitor MG-132. The SP-C
∆exon4 cell line was exquisitely sen-
sitive to proteasome inhibition. The majority of cells retracted 
and detached from the plate after treatment with 250 nM 
MG-132 for 18 h, and a more pronounced effect was detected at 
the 500 nM of concentration (Fig. 6 a [g and h]).  SP-C
wt cells 
were minimally affected by similar treatment (Fig. 6 a [a–d]). 
Cell viability was decreased  10% in SP-C
wt cells and 50% in 
SP-C
∆exon4 cells treated with 500 nM MG-132 (Fig. 6 b).
To determine whether MG-132–induced cytotoxicity was 
associated with SP-C
∆exon4 accumulation, immunoblot analysis 
Figure 6.  SP-C
∆exon4 sensitizes cells to proteasome inhibition. (a) SP-C
wt and SP-C
∆exon4 clonal cell lines were plated at equal cell densities and treated 
with the proteasome inhibitor MG-132 at the indicated concentrations. Phase photographs of the cells were captured directly from the culture plate 
18 h after treatment. Bars, 50 μm. (b) MTS assay of cells treated as indicated in a. Results are presented as means ± SD (error bars); each   determination 
was performed in triplicate, and the experiment was repeated three times. *, P < 0.05 compared with SP-C
∆exon4 unRx; #, P < 0.05 compared with 
SP-C
wt unRx. (c) Immunoblots of whole cell lysates from clonal cell lines expressing SP-C
wt or SP-C
∆exon4 after MG-132 treatment. Immunoblots were 
probed with antibodies against proSP-C antibody or actin (loading control). (d) Clonal cell lines expressing SP-C
wt or SP-C
∆exon4 were cultured in the 
presence (+) or absence (−) of 500 nM MG-132 for 18 h. Total RNA was isolated from cells and subjected to RT-PCR analysis with primers spanning 
the intron of unspliced XBP-1 mRNA. XBP-1(u) denotes unspliced, inactive XBP-1; XBP-1(s) denotes spliced, active XBP-1; products were separated 
on a 4% agarose gel.ADAPTATION TO MISFOLDED SP-C • BRIDGES ET AL.    403
stitutive expression of misfolded SP-C and that NF-κB played a 
pivotal role in the adaptive response. Infection of cells expressing 
SP-C
∆exon4 with RSV resulted in enhanced cytotoxicity associated 
with decreased proteasome function, accumulation of the mutant 
Figure 7.  Accumulation of SP-C
𝖫exon4 is associated with cell death. 
(a) SP-C
wt (left) and SP-C
∆exon4 (right) clonal cell lines were plated at equal 
cell density on poly-D-lysine–coated coverslips and treated with 500 nM 
MG-132. 18 h after treatment, the cells that remained attached to the cov-
erslips were ﬁ  xed, permeabilized, and stained with H33342 dye to visual-
ize the nuclear architecture. Higher magniﬁ  cation of one representative cell 
is shown in the insets. Bars, 50 μm; (insets), 10 μm. (b) Clonal cell lines ex-
pressing SP-C
wt or SP-C
∆exon4 were cultured in the presence or absence of 
MG-132 at the indicated concentrations, harvested 18 h after treatment, 
and subjected to immunoblot analysis with a caspase-3 antibody that de-
tects both the precursor and cleaved isoforms. (c) Clonal cell lines express-
ing SP-C
wt or SP-C
∆exon4 were infected with RSV at the indicated 
plaque-forming units s for 24 h. Cell lysates were harvested and subjected 
to immunoblot analysis with a caspase-3 antibody. SP-C
∆exon4 cells were 
treated with MG-132 overnight for a positive control. (d) Immunohistochem-
istry for cleaved caspase-3 on lung sections from wild-type (WT) or trans-
genic mice (TG#2) in which SP-C
∆exon4 was expressed in the distal lung 
epithelium. Closed arrowheads represent cleaved caspase-3–positive cell 
debris, and open arrowheads represent red blood cells. Bars, 20 μm.
was performed with a proSP-C antibody after MG-132 treat-
ment. There was a dose-dependent increase in SP-C
∆exon4 pro-
tein, whereas levels of the SP-C
wt protein were unaffected by 
MG-132 treatment (Fig. 6 c). Accumulation of unfolded pro-
teins in the ER results in the activation of the IRE1–XBP-1 
pathway (for review see Harding et al., 2002). Active XBP-1 
was not detected in SP-C
wt cells after MG-132 treatment; in 
contrast, robust activation of XBP-1 was detected in SP-C
∆exon4 
cells after proteasome inhibition (Fig. 6 d). Collectively, these 
results demonstrate that proteasome inhibition resulted in dose-
dependent cytotoxicity associated with the accumulation of 
SP-C
∆exon4 and the activation of XBP-1.
Accumulation of SP-C
𝖫exon4 is associated 
with apoptosis
To determine whether the accumulation of SP-C
∆exon4 after pro-
teasome inhibition was associated with apoptosis, cell lines 
were treated with MG-132 and stained with the fl  uorescent 
DNA-intercalating dye H33342 to assess nuclear architecture. 
Cells expressing SP-C
wt showed a diffuse, uniform staining of 
the nucleus typical of viable, healthy cells (Fig. 7 a, left panel 
and inset).  Although the majority of cells expressing SP-C
∆exon4 
detached from the plate after MG-132 treatment and were ex-
cluded from this analysis, the cells that remained attached ex-
hibited punctuate staining and nuclear condensation that is 
consistent with apoptosis (Fig. 7 a, right panel and inset). Fur-
thermore, treatment of SP-C
∆exon4–expressing HEK293 cells 
with MG-132 for 18 h resulted in the activation of caspase-3 
(Fig. 7 b). Caspase-3 activation was not detected in SP-C
wt cells 
treated with MG-132, indicating that this event was specifi  c for 
cells expressing mutant SP-C
∆exon4 (Fig. 7 b). As previously re-
ported, the expression of SP-C
∆exon4 in the distal lung epithelium 
of transgenic mice resulted in cytotoxicity associated with lung 
dysmorphogenesis (Bridges et al., 2003). Immunohistochemis-
try was performed on fetal lung sections from a transgene-
  positive animal (Fig. 7 d, TG#2) and a wild-type littermate 
control (Fig. 7 d, WT) with an antibody that detects the cleaved 
isoform of caspase-3. Robust staining for active caspase-3 was 
detected in sloughed epithelial cells in the distal airway and iso-
lated intact epithelial cells in the transgenic animal, whereas 
lung     epithelial cells in the wild-type animal were negative (Fig. 7 d). 
Together, these results demonstrate that the accumulation of 
SP-C
∆exon4, induced by proteasome inhibition in vitro or overex-
pression in vivo, was associated with the activation of apoptotic 
pathways. In contrast, RSV infection resulted in specifi  c, exten-
sive death of SP-C
∆exon4–expressing cells (Fig. 4) without evi-
dence of caspase-3 activation (Fig. 7 c).
Discussion
The SP-C
∆exon4 mutation was chosen for these experiments because 
of its link to ILD in human patients (Nogee et al., 2001, 2002), 
the severity of this mutation on the structure of the proprotein, 
and its association with cytotoxicity and lung dysmorphogenesis 
when expressed in transgenic mice (Bridges et al., 2003). Results 
of experiments performed in this study using stably transfected 
cells indicated that the SP-C
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proprotein, and cell death. Collectively, these results suggest that 
adaptation to chronic ER stress imposed by misfolded SP-C may 
promote resistance to ILD, whereas environmental insults, such 
as viral infection, may trigger the onset of disease in patients with 
mutations in SFTPC.
Although the effects of acute ER stress, imposed by xeno-
toxic agents such as thapsigargin and tunicamycin, are well es-
tablished, little is known about the molecular pathways involved 
in adaptation to chronic ER stress imposed by a misfolded 
protein. The lack of a cytotoxic response coupled with the ab-
sence of ER stress induction in SP-C
∆exon4 clonal cells suggested 
that these cells successfully adapted to the constitutive expres-
sion of misfolded SP-C. Several lines of evidence support this 
hypothesis. First, the level of SP-C mRNA in the SP-C
∆exon4 cell 
line was comparable with that in the SP-C
wt cell line, thus ex-
cluding low expression of the mutant protein as a reason for the 
survival of SP-C
∆exon4 cells. Second, in contrast to the wild-type 
protein, SP-C
∆exon4 protein was barely detectable, indicating that 
the misfolded proprotein was recognized as terminally mis-
folded and rapidly degraded via the ERAD pathway. Further-
more, chronic expression of SP-C
∆exon4 was associated with 
modestly reduced proteasome function that is consistent with 
near saturation of this degradative pathway. Third, components 
of the ER stress/UPR pathways were not transcriptionally up-
regulated in the clonal SP-C
∆exon4 cell line, which is in marked 
contrast to results in transiently transfected HEK293 cells 
(Bridges et al., 2003; Mulugeta et al., 2005). Fourth, chronic 
expression of SP-C
∆exon4 was associated with differential ex-
pression of both pro- and anti-apoptotic genes, approximately 
half of which contained putative NF-κB–binding sites in their 
promoters. Lastly, the inhibition of NF-κB, which is known to 
promote cell survival in response to a variety of stresses, re-
sulted in the death of SP-C
∆exon4 cells. Collectively, these results 
are consistent with an NF-κB–dependent adaptive response to 
chronic ER stress imposed by the constitutive expression of 
SP-C
∆exon4. Although the induction of other molecular pathways 
involved in cell survival may occur, the activation of NF-κB 
  appears to be critical for survival in HEK293 cells that consti-
tutively express SP-C
∆exon4.
The role of NF-κB in the regulation of cytokine- stimulated 
proinfl  ammatory gene expression is well established (Li and 
Verma, 2002). In this study, up-regulation of proinfl  ammatory 
cytokines was not detected by microarray analyses; however, it 
is certainly possible that infl  ammation associated with lung in-
jury and repair contributes to pathogenesis in vivo. NF-κB ac-
tivity is also increased in response to the accumulation of 
transmembrane proteins in the ER, including the E3/19k protein 
of adenovirus (Pahl et al., 1996), middle human hepatitis B sur-
face protein (Meyer et al., 1992), expression of major histocom-
patibility complex class 1 in the absence of β2-microglobin 
protein (Pahl et al., 1996), and p450 (Szczesna-Skorupa et al., 
2004). In addition, transient expression of the misfolded Z vari-
ant of α1-antitrypsin in CHO and HEK293 cells resulted in 
NF-κB activation associated with decreased levels of IκBα and 
IκBβ (Lawless et al., 2004). Activation of NF-κB in response to 
the accumulation of newly synthesized membrane or misfolded 
secretory proteins is referred to as the ER overload response. 
Constitutive activation of NF-κB promotes survival of a wide 
range of cells, including B cells, hepatic cells, and cancer cells, 
and is a major target for cancer therapy (Kucharczak et al., 
2003). NF-κB promotes cell survival, in part, by activating anti-
apoptotic genes, including members of the inhibitor of apopto-
sis family, TRAF1 and TRAF2, and the Bcl2 homologues 
Bfl  -1/A1 and Bcl-Xl (Kucharczak et al., 2003). Recent studies 
using tunicamycin and thapsigargin as stressor agents demon-
strated an association between ER stress–induced PERK activa-
tion, eIF2α phosphorylation, and NF-κB activation (Jiang 
et al., 2003; Deng et al., 2004), effectively linking the UPR and 
the ER overload response. Although a defi  nitive role for NF-κB 
activation in response to ER stress has not been established, it is 
thought to promote cell survival in this context.
Transient transfection of HEK293 cells with SP-C
∆exon4 
resulted in specifi  c up-regulation of BiP, XBP-1, and HedJ1, 
which is consistent with the induction of UPR and ERAD to 
promote clearance of the misfolded protein and the alleviation 
of ER stress (Bridges et al., 2003; Mulugeta et al., 2005). In 
contrast, the constitutive expression of SP-C
∆exon4 resulted in the 
differential expression of apoptosis-related genes with an ap-
parent balance shifted toward NF-κB–dependent anti-apoptotic 
responses. Identifi  cation of environmental triggers that tip the 
balance toward apoptosis/cell death are clearly important 
for understanding disease pathogenesis in humans with SFTPC 
mutations. ILD is often associated with infection and/or infl  am-
mation (Vassallo, 2003; Noble and Homer, 2004). The marked 
variability in severity and age of onset of lung disease in the 
SP-C
L188Q pedigrees suggested that environmental factors 
might be involved in triggering the onset of ILD (Thomas 
et al., 2002a; Chibbar et al., 2004). Consistent with this 
hypothesis, five individuals in the SP- C
L188Q kindreds were 
diagnosed with viral infection before the manifestation of lung 
disease. Importantly, cells stably expressing SP-C
∆exon4 were 
much more susceptible to viral-induced cell death, sug-
gesting that infection may be an environmental trigger for ILD.
Although RSV infection in vivo is associated with epi-
thelial cell damage and cellular desquamation, these cyto-
pathic effects are primarily mediated by an augmented immune 
response initiated by the infected host cells rather than viral-
induced cell death. In support of this hypothesis, mice de-
pleted of CD4 and CD8 cells exhibited persistent viral 
replication without illness (Graham et al., 1991). Furthermore, 
RSV infection of cultured airway epithelial cells (MOI of 
 20; i.e., twice the dose used in this study) did not result in 
cytopathology (Zhang et al., 2002). Consistent with these fi  nd-
ings, HEK293 cells constitutively expressing SP-C
wt exhibited 
relatively little cell death in response to RSV infection (Fig. 
4 a). In marked contrast, RSV infection of cells expressing 
SP-C
∆exon4 resulted in extensive cell death associated with pro-
teasome inhibition and accumulation of mutant proprotein. 
In vivo, injury of alveolar epithelial cells is an early event in pro -
gressive pulmonary fi  brosis. Impaired reepithelialization leads 
to sustained proliferation/activation of interstitial fi  broblasts 
and myofi  broblasts, resulting in the accumulation of extracel-
lular matrix and, ultimately, fi  brosis (Thannickal et al., 2004; 
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individuals to severe RSV pneumonia may further contribute 
to variability in the severity and onset of the disease (Peebles 
and Graham, 2005).
Although RSV infection was specifi  cally cytotoxic for 
SP-C
∆exon4–expressing cells, the molecular pathway leading to 
cell death is not clear. Cell death did not appear to be apoptosis 
dependent, as caspase-3 cleavage was undetectable in the RSV-
infected cells (Fig. 7 c). RSV has been shown to inhibit apopto-
sis of cultured epithelial cells via the activation of EGF 
receptor–extracellular signal-regulated kinase and PI3K–AKT 
signaling pathways, thereby promoting self-replication (Thomas 
et al., 2002b; Monick et al., 2005). In this study, RSV-induced 
cytotoxicity was associated with proteasome dysfunction, accu-
mulation of the mutant proprotein SP-C
∆exon4, and pronounced 
activation of the UPR. Induction of ER stress and proteasome 
inhibition in RSV-infected SP-C
∆exon4 cells may be related, in 
part, to forced synthesis of viral membrane proteins, including 
the F, G, and SH proteins. UPR activation was higher in 
SP-C
∆exon4 cells than in SP-C
wt cells, suggesting that the produc-
tion of RSV membrane proteins superimposed on the expres-
sion of misfolded SP-C
∆exon4 protein may overwhelm the 
degradative capacity of the proteasome, leading to accumula-
tion of cytotoxic forms of SP-C
∆exon4 and subsequent cell death. 
Therefore, it is possible that proteasome dysfunction and accu-
mulation of SP-C
∆exon4 drives the cell down a nonapoptotic cell 
death pathway in the presence of RSV. In contrast, accumula-
tion of SP-C
∆exon4 in transgenic mice and MG-132–treated cells 
(i.e., in the absence of RSV infection) resulted in caspase-3 activa-
tion, which is typical of apoptosis (Fig. 7 c; Bridges et al., 2003).
Based on the fi  ndings of this study, the following model is 
proposed. SP-C
wt protein is correctly folded and exported from 
the ER, whereas SP-C
∆exon4 is terminally misfolded and de-
graded by a proteasome-dependent pathway. Constitutive ex-
pression of terminally misfolded SP-C
∆exon4 results in chronic 
ER stress and an NF-κB–dependent cytoprotective response. 
Superimposition of a secondary stress, such as RSV infection, 
on the constitutive expression of SP-C
∆exon4 leads to proteasome 
dysfunction, accumulation of SP-C
∆exon4, and cytotoxicity. 
  Accumulation of SP-C
∆exon4 and cytotoxicity may contribute to 
the pathogenesis of ILD associated with mutations in SFTPC.
Materials and methods
Reagents
Recombinant TNFα protein was obtained from PeproTech. The MTS reduc-
tion assay kit and Dual-Luciferase Reporter Assay System were purchased 
from Promega; MTS reduction assays were performed in 96-well plates 
  according to the manufacturer’s protocol. MG-132, SN50, and control 
peptide (SN50mut) were obtained from EMD Biosciences.
SP-C cDNA constructs and generation of stably transfected cell lines
Full-length human wild-type SP-C (SP-C
wt) cDNA and SP-C
∆exon4, generated 
as previously described (Bridges et al., 2003), were subcloned into 
pTRE2-Hyg (BD Biosciences) to generate SP-C
wt/pTRE2-Hyg and 
SP-C
∆exon4/pTRE2-Hyg. To generate stably transfected cell lines, HEK293 
Tet-Off cells (CLONTECH Laboratories, Inc.) were transiently transfected 
with   SP-C
wt/pTRE2-Hyg or SP-C
∆exon4/pTRE2-Hyg using LipofectAMINE 
2000 (Invitrogen) in the presence of 250 μg/ml hygromycin B as the selec-
tion agent. Doxycycline was present in the media during the selection pro-
cess to obtain regulatable lines (i.e., expression of SP-C
wt or SP-C
∆exon4 was 
dependent on doxycycline withdrawal). However, all lines that were 
  initially regulatable eventually reverted to constitutive expression of the 
transgene. Therefore, SP-C
wt or SP-C
∆exon4 cells for this study were cultured 
in the absence of doxycycline and G418 (selection agent for the tTA cassette). 
Clonal colonies were isolated, ampliﬁ  ed, and screened for integration of 
the transgene by RT-PCR using SP-C–speciﬁ  c primers and Western analyses 
using an antibody directed against the NH2-terminal peptide of proSP-C 
(Bridges et al., 2003).
RNA isolation, RT-PCR, and microarray analysis
Total RNA for RT-PCR and real-time PCR analysis was isolated using the 
acidiﬁ  ed guanidinium method (Chomczynski and Sacchi, 1987), treated 
with DNase I (DNA free; Ambion), and reverse transcribed into cDNA us-
ing SuperScript II Reverse Transcriptase (Invitrogen). Forward and reverse 
primer sequences for human XBP-1 are 5′-G  G  A  C  T  T  A  A  G  A  C  A  G  C  G  C  T  T  G  G  -3′ 
and 5′-T  G  A  G  A  G  G  T  G  C  T  T  C  C  T  C  G  A  T  T  -3′. PCR reactions for XBP-1 were 
performed for 35 cycles, and products were separated on 4% agarose 
gels. Veriﬁ  cation of microarray data for selected genes was performed by 
real-time PCR analysis with a SmartCycler (Cepheid) using reaction condi-
tions as previously described (Hyatt et al., 2004).
RNA samples for microarray analysis were prepared as previously 
described (DeFelice et al., 2003) and hybridized to the GeneChip Hu-
man Genome U133 Set (HG-U133A and HG-U133B; Affymetrix, Inc.) 
according to the manufacturer’s protocol. Affymetrix Microarray Suite 5.0 
was used to scan and quantitate the gene chips under default scan set-
tings. Normalization was performed using the Robust Multichip Average 
model (Irizarry et al., 2003a,b). Data were further analyzed using Signiﬁ  -
cance Analysis Of Microarrays (Tusher et al., 2001) and Genespring 7.2 
(Silicon Genetics). Detection of differential expression was performed us-
ing random permutation and Welch’s approximate t test for mutant and 
control groups at P ≤ 0.01, false discovery rate ≤ 10%, a minimal of 
twofold changes in absolute ratio, and a minimum of two present calls by 
Affymetrix algorithm in three samples with the relative higher expression. 
Gene ontology anal  ysis was performed using the database for annotation, 
visualization, and integrated discovery (Dennis et al., 2003). Potential 
  protein–protein interactions were identiﬁ  ed using PathwayAssist (Ariadne 
Genomics). NF-κB–binding sites (G  G  G  A  C  T  T  T  C  C  ) were scanned in −2-kb 
promoter   regions of all differentially expressed genes from microarray 
analysis using MatInspector (Genomatix), allowing a maximum of 
one mismatch.
Cell culture and Western analysis
HEK293 stable cell lines were propagated as previously described (Bridges 
et al., 2003). Cell lysate preparation, protein standardization, and West-
ern analysis were performed as previously described (Bridges et al., 
2003). Nuclear extracts were isolated as previously described (Odoms 
et al., 2004). Antibody sources are as follows: anti–proSP-C (Vorbroker 
et al., 1995), anti–caspase-3 (Cell Signaling), antihistone H2B (Imgenex), 
anti-p65 subunit of NF-κB (Santa Cruz Biotechnology, Inc.), and anti-actin 
(Bridges et al., 2003).
Confocal ﬂ  uorescence
Cells for confocal microscopy were prepared as previously described 
(Conkright et al., 2001). Primary antibodies included a polyclonal 
anti–proSP-C (Bridges et al., 2003), a monoclonal anti-LAMP1/CD107A 
(Research Diagnostics, Inc.), and a monoclonal anti-KDEL (StressGen Bio-
technologies). Secondary antibodies included anti–rabbit FITC-conjugated 
and anti–mouse Texas red–conjugated secondary antibodies (Jackson 
  ImmunoResearch Laboratories). Vectashield Hardset (Vector Laboratories) 
was used as the mounting medium. Fluorescence was visualized on 
a confocal microscope (LSM510; Carl Zeiss MicroImaging, Inc.) using 
FITC/Texas red ﬁ  lters and a 40× NA 1.3 objective.
Fluorescence and phase microscopy of live cells was performed on 
a microscope (LX70; Olympus) equipped with a UV lamp, FITC/Texas red 
ﬁ  lters, and a 20× NA 0.40 objective. Images were captured with a digi-
tal camera (MagnaFire; Optronics) using MagnaFire software (Optronics). 
For cell death assays, 2 μl of 1 mg/ml PI solution was added to live cells 
for 10 min at room temperature before visualization.
Flow cytometry
HEK293 cells were detached from the culture plate 24 h after RSV infec-
tion/transient transfection by treatment with trypsin/EDTA, washed once 
with PBS, and resuspended in FACS buffer consisting of PBS with 0.1% FBS 
and 0.05% sodium azide. Cell-associated ﬂ  uorescence was measured on 
a FACScalibur ﬂ  ow cytometer using CellQuest software (BD Biosciences). 
For each sample, 20,000 events were acquired.JCB • VOLUME 172 • NUMBER 3 • 2006  406
Immunohistochemistry
Immunohistochemistry was performed on mouse fetal lung samples that 
were previously described (Bridges et al., 2003) using an antibody that 
detects the cleaved form of caspase-3 (R&D Systems) at a 1:5,000 dilution. 
Localization of antigen–antibody complexes was performed as previously 
described (Bridges et al., 2003).
RSV production and infection protocol
The A2 strain of RSV was ampliﬁ  ed, puriﬁ  ed, and quantitated in Hep2 as 
previously described (LeVine et al., 1999). Clonal cell lines were infected 
with RSV using a previously established protocol for adenoviral infection 
(Bridges et al., 2003). For studies in which proteasome activity was as-
sessed after RSV infection, the proteasome sensor plasmid pZsProSensor-1 
(CLONTECH Laboratories, Inc.) was transfected into the cells using Lipo-
fectAMINE 2000 24 h before RSV infection. The pZsProSensor-1 plasmid 
encodes a destabilized GFP consisting of amino acids 422–461 of the 
degradation domain of mouse ornithine decarboxylase protein fused to the 
COOH terminus of the naturally occurring reef coral Zoanthus species pro-
tein (ZsGreen). This fusion protein is rapidly degraded by the proteasome 
in an ubiquitin-independent manner.
Luciferase constructs and assays
The NF-κB–dependent ELAM-1 promoter-driven ﬁ  reﬂ   y luciferase plasmid 
(pELAM-luc) was obtained from M.J. Fenton (University of Maryland, Bal-
timore, MA). The p5xATF6GL3 plasmid (also known as the UPR element 
luciferase reporter) was obtained from R. Prywes (Columbia University, 
New York, NY). The IκB SR expression plasmid was obtained from R. Hay 
(University of St. Andrews, St. Andrews, Scotland). The pRL-TK plasmid 
was purchased from Promega. 400 ng of ﬁ  reﬂ  y luciferase construct was 
cotransfected with 50 ng pRL-TK using LipofectAMINE 2000 (Invitrogen). 
Cells were harvested 48 h after transfection, and luciferase activity was 
quantiﬁ  ed using the Dual-Luciferase Assay system in a Berthold multitube 
luminometer. Data are plotted as the ratio of ﬁ  reﬂ  y/renilla activity to cor-
rect for transfection efﬁ  ciency among samples.
Statistics
Data were analyzed with InStat version 3.0 (GraphPad Software). Values 
are presented as means ± SD. Multiple comparisons were made by analy-
sis of variance between groups using the Tukey-Kramer multiple compari-
sons test, and paired samples were analyzed by t tests. In both cases, 
statistical signiﬁ  cance was deﬁ  ned as P < 0.05 or less.
Online supplemental material
Fig. S1 is a model of functional associations between differentially expressed 
genes in SP-C
∆exon4 cells associated with apoptosis using   PathwayAssist 
software. Table SI lists descriptive information of apoptosis-associated 
genes from the model in Fig. S1. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200508016/DC1.
The authors would like to thank Chen Xia Duan, Mei Wang, Senad Divanovic, 
Al Senft, Mukund Raghavan, and Xiaofei Shangguan for technical assistance 
and/or advice.
This work is supported by National Institutes of Health awards 
PO1-HL61646 and P50-HL56387 to T.E. Weaver.
Submitted: 2 August 2005
Accepted: 22 December 2005
References
Bridges, J.P., S.E. Wert, L.M. Nogee, and T.E. Weaver. 2003. Expression of a 
human surfactant protein C mutation associated with interstitial lung 
disease disrupts lung development in transgenic mice. J. Biol. Chem. 
278:52739–52746.
Cameron, H.S., M. Somaschini, P. Carrera, A. Hamvas, J.A. Whitsett, S.E. Wert, 
G. Deutsch, and L.M. Nogee. 2005. A common mutation in the surfactant 
protein C gene associated with lung disease. J. Pediatr. 146:370–375.
Chibbar, R., F. Shih, M. Baga, E. Torlakovic, K. Ramlall, R. Skomro, D.W. 
Cockcroft, and E.G. Lemire. 2004. Nonspecifi  c interstitial pneumonia 
and usual interstitial pneumonia with mutation in surfactant protein C in 
familial pulmonary fi  brosis. Mod. Pathol. 17:973–980.
Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation 
by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. 
Biochem. 162:156–159.
Conkright, J.J., J.P. Bridges, C.L. Na, W.F. Voorhout, B. Trapnell, S.W. Glasser, and 
T.E. Weaver. 2001. Secretion of surfactant protein C, an integral membrane pro-
tein, requires the N-terminal propeptide. J. Biol. Chem. 276:14658–14664.
DeFelice, M., D. Silberschmidt, R. DiLauro, Y. Xu, S.E. Wert, T.E. Weaver, C.J. 
Bachurski, J.C. Clark, and J.A. Whitsett. 2003. TTF-1 phosphorylation is 
required for peripheral lung morphogenesis, perinatal survival, and tissue 
specifi  c gene expression. J. Biol. Chem. 278:35574–35583.
Dell’Angelica, E.C., C. Mullins, S. Caplan, and J.S. Bonifacino. 2000. Lysosome-
related organelles. FASEB J. 14:1265–1278.
Deng, J., P.D. Lu, Y. Zhang, D. Scheuner, R.J. Kaufman, N. Sonenberg, H.P. 
Harding, and D. Ron. 2004. Translational repression mediates activation 
of nuclear factor kappa B by phosphorylated translation initiation factor 2. 
Mol. Cell. Biol. 24:10161–10168.
Dennis, G., Jr., B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, H.C. Lane, and 
R.A. Lempicki. 2003. DAVID: Database for Annotation, Visualization, 
and Integrated Discovery. Genome Biol. 4:P3.
Graham, B.S., L.A. Bunton, P.F. Wright, and D.T. Karzon. 1991. Role of T lym-
phocyte subsets in the pathogenesis of primary infection and rechallenge 
with respiratory syncytial virus in mice. J. Clin. Invest. 88:1026–1033.
Harding, H.P., M. Calfon, F. Urano, I. Novoa, and D. Ron. 2002. Transcriptional 
and translational control in the mammalian unfolded protein response. 
Annu. Rev. Cell Dev. Biol. 18:575–599.
Hetz, C., M. Russelakis-Carneiro, K. Maundrell, J. Castilla, and C. Soto. 2003. 
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of 
pathological prion protein. EMBO J. 22:5435–5445.
Hitomi, J., T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. 
Manabe, S. Yamagishi, Y. Bando, K. Imaizumi, et al. 2004. Involvement 
of caspase-4 in endoplasmic reticulum stress-induced apoptosis and 
A{β}-induced cell death. J. Cell Biol. 165:347–356.
Hyatt, B.A., X. Shangguan, and J.M. Shannon. 2004. FGF-10 induces SP-C and 
Bmp4 and regulates proximal-distal patterning in embryonic tracheal 
 epithelium.  Am. J. Physiol. Lung Cell. Mol. Physiol. 287:L1116–L1126.
Irizarry, R.A., B.M. Bolstad, F. Collin, L.M. Cope, B. Hobbs, and T.P. Speed. 
2003a. Summaries of Affymetrix GeneChip probe level data. Nucleic 
Acids Res. 31:e15.
Irizarry, R.A., B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, 
and T.P. Speed. 2003b. Exploration, normalization, and summaries of high 
density oligonucleotide array probe level data. Biostatistics. 4:249–264.
Jiang, H.Y., S.A. Wek, B.C. McGrath, D. Scheuner, R.J. Kaufman, D.R. Cavener, 
and R.C. Wek. 2003. Phosphorylation of the alpha subunit of eukaryotic 
initiation factor 2 is required for activation of NF-kappaB in response to 
diverse cellular stresses. Mol. Cell. Biol. 23:5651–5663.
Kucharczak, J., M.J. Simmons, Y. Fan, and C. Gelinas. 2003. To be, or not to 
be: NF-kappaB is the answer–role of Rel/NF-kappaB in the regulation of 
apoptosis. Oncogene. 22:8961–8982.
Lawless, M.W., C.M. Greene, A. Mulgrew, C.C. Taggart, S.J. O’Neill, and N.G. 
McElvaney. 2004. Activation of endoplasmic reticulum-specifi  c stress re-
sponses associated with the conformational disease Z alpha 1-antitrypsin 
defi  ciency. J. Immunol. 172:5722–5726.
LeVine, A.M., J. Gwozdz, J. Stark, M. Bruno, J. Whitsett, and T. Korfhagen. 
1999. Surfactant protein-A enhances respiratory syncytial virus clearance 
in vivo. J. Clin. Invest. 103:1015–1021.
Li, Q., and I.M. Verma. 2002. NF-kappaB regulation in the immune system. Nat. 
Rev. Immunol. 2:725–734.
Meyer, M., W.H. Caselmann, V. Schluter, R. Schreck, P.H. Hofschneider, and 
P.A. Baeuerle. 1992. Hepatitis B virus transactivator MHBst: activation 
of NF-kappa B, selective inhibition by antioxidants and integral mem-
brane localization. EMBO J. 11:2991–3001.
Monick, M.M., K. Cameron, J. Staber, L.S. Powers, T.O. Yarovinsky, J.G. Koland, 
and G.W. Hunninghake. 2005. Activation of the epidermal growth factor 
receptor by respiratory syncytial virus results in increased infl  ammation 
and delayed apoptosis. J. Biol. Chem. 280:2147–2158.
Mulugeta, S., V. Nguyen, S.J. Russo, M. Muniswamy, and M.F. Beers. 2005. 
A surfactant protein C precursor protein BRICHOS domain mutation 
causes endoplasmic reticulum stress, proteasome dysfunction, and cas-
pase 3 activation. Am. J. Respir. Cell Mol. Biol. 32:521–530.
Nakagawa, T., H. Zhu, N. Morishima, E. Li, J. Xu, B.A. Yankner, and J. Yuan. 
2000. Caspase-12 mediates endoplasmic-reticulum-specifi  c  apoptosis 
and cytotoxicity by amyloid-beta. Nature. 403:98–103.
Noble, P.W., and R.J. Homer. 2004. Idiopathic pulmonary fi  brosis: new insights 
into pathogenesis. Clin. Chest Med. 25:749–758.
Noble, P.W., and R.J. Homer. 2005. Back to the future: historical perspective 
on the pathogenesis of idiopathic pulmonary fi  brosis. Am. J. Respir. Cell 
Mol. Biol. 33:113–120.
Nogee, L.M., A.E. Dunbar, S.E. Wert, F. Askin, A. Hamvas, and J.A. Whitsett. 
2001. A mutation in the surfactant protein C gene associated with familial 
interstitial lung disease. N. Engl. J. Med. 344:573–579.ADAPTATION TO MISFOLDED SP-C • BRIDGES ET AL.    407
Nogee, L.M., A.E. Dunbar, S. Wert, F. Askin, A. Hamvas, and J.A. Whitsett. 
2002. Mutations in the surfactant protein C gene associated with intersti-
tial lung disease. Chest. 121:20S–21S.
Odoms, K., T.P. Shanley, and H.R. Wong. 2004. Short-term modulation of inter-
leukin-1beta signaling by hyperoxia: uncoupling of IkappaB kinase acti-
vation and NF-kappaB-dependent gene expression. Am. J. Physiol. Lung 
Cell. Mol. Physiol. 286:L554–L562.
Oyadomari, S., and M. Mori. 2004. Roles of CHOP/GADD153 in endoplasmic 
reticulum stress. Cell Death Differ. 11:381–389.
Pahl, H.L., and P.A. Baeuerle. 1995. Expression of infl  uenza virus hemagglutinin 
activates transcription factor NF-kappa B. J. Virol. 69:1480–1484.
Pahl, H.L., M. Sester, H.G. Burgert, and P.A. Baeuerle. 1996. Activation of tran-
scription factor NF-κB by the adenovirus E3/19K protein requires its ER 
retention. J. Cell Biol. 132:511–522.
Peebles, R.S., Jr., and B.S. Graham. 2005. Pathogenesis of respiratory syncytial 
virus infection in the murine model. Proc. Am. Thorac. Soc. 2:110–115.
Schroder, M., and R.J. Kaufman. 2005. The mammalian unfolded protein 
 response.  Annu. Rev. Biochem. 74:739–789.
Szczesna-Skorupa, E., C.D. Chen, H. Liu, and B. Kemper. 2004. Gene expres-
sion changes associated with the endoplasmic reticulum stress response 
induced by microsomal cytochrome P450 overproduction. J. Biol. Chem. 
279:13953–13961.
Tardif, K.D., K. Mori, R.J. Kaufman, and A. Siddiqui. 2004. Hepatitis C virus 
suppresses the IRE1-XBP1 pathway of the unfolded protein response. 
J. Biol. Chem. 279:17158–17164.
Thannickal, V.J., G.B. Toews, E.S. White, J.P. Lynch III, and F.J. Martinez. 2004. 
Mechanisms of pulmonary fi  brosis. Annu. Rev. Med. 55:395–417.
Thomas, A.Q., K. Lane, J. Phillips III, M. Prince, C. Markin, M. Speer, 
D.A. Schwartz, R. Gaddipati, A. Marney, J. Johnson, et al. 2002a. 
Heterozygosity for a surfactant protein C gene mutation associ-
ated with usual interstitial pneumonitis and cellular nonspecifi  c in-
terstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 
165:1322–1328.
Thomas, K.W., M.M. Monick, J.M. Staber, T. Yarovinsky, A.B. Carter, and G.W. 
Hunninghake. 2002b. Respiratory syncytial virus inhibits apoptosis and 
induces NF-kappa B activity through a phosphatidylinositol 3-kinase-
 dependent  pathway.  J. Biol. Chem. 277:492–501.
Tusher, V.G., R. Tibshirani, and G. Chu. 2001. Signifi  cance analysis of micro-
arrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. 
USA. 98:5116–5121.
Urano, F., X. Wang, A. Bertolotti, Y. Zhang, P. Chung, H.P. Harding, and D. Ron. 
2000. Coupling of stress in the ER to activation of JNK protein kinases by 
transmembrane protein kinase IRE1. Science. 287:664–666.
Vassallo, R. 2003. Viral-induced infl   ammation in interstitial lung diseases. 
Semin. Respir. Infect. 18:55–60.
Vorbroker, D.K., S.A. Profi  tt, L.M. Nogee, and J.A. Whitsett. 1995. Aberrant 
processing of surfactant protein C (SP-C) in hereditary SP-B defi  ciency. 
Am. J. Physiol. 268:L647–L656.
Wang, W.J., S. Mulugeta, S.J. Russo, and M.F. Beers. 2003. Deletion of exon 
4 from human surfactant protein C results in aggresome formation and 
generation of a dominant negative. J. Cell Sci. 116:683–692.
Weaver, T.E., C.L. Na, and M. Stahlman. 2002. Biogenesis of lamellar bodies, 
lysosome-related organelles involved in storage and secretion of pulmo-
nary surfactant. Semin. Cell Dev. Biol. 13:263–270.
Yoshida, H., T. Matsui, N. Hosokawa, R.J. Kaufman, K. Nagata, and K. Mori. 
2003. A time-dependent phase shift in the Mammalian unfolded protein 
response. Dev. Cell. 4:265–271.
Zhang, L., M.E. Peeples, R.C. Boucher, P.L. Collins, and R.J. Pickles. 2002. 
Respiratory syncytial virus infection of human airway epithelial cells is 
polarized, specifi  c to ciliated cells, and without obvious cytopathology. 
J. Virol. 76:5654–5666.